Key Takeaways
- Guidance reset, not a structural break: FY23 top line revised to ₹1,650–1,700 crore from ₹2,000 crore, driven by subsidiary demand slowdown and textile headwinds, but management frames this as a second-half soft patch with recovery already visible in some pockets.
- Gross margin recovery is the real story: Consolidated gross margin jumped to 30% from 25% YoY as RM prices moderated, and the company is actively tilting the mix toward higher-margin products.
- Subsidiary integration is working, but lumpy: Both Unitop and Tristar delivered strong 9M YoY performance post-acquisition, yet Q3 exposed agro seasonality and export destocking risks that make quarterly run rates uneven.
- The lost-customer hole is being filled: A key MNC addition in HPPC largely offset a customer whose run rate went to zero, and management expects to fully negate the loss within a couple of quarters.
- What to watch next quarter: Whether Tristar exports normalize by mid-Q4 as guided, whether Unitop volumes pick up from mid-Feb, and whether the FY24 15–20% growth commitment survives the Q4 print.
The Guidance Reset
- FY23 top line halved from ambition: The original ₹2,000 crore target is off the table; management now expects to close around ₹1,650–1,700 crore, blaming a weak second half across subsidiaries and textiles.
- EBITDA revised down too: FY23 EBITDA is now seen at ₹220–230 crore, down from the earlier ₹250 crore, though margin improvement partially cushions the revenue miss.
- FY24 commitment stays bold: Management is guiding for at least 15–20% top-line growth in FY24 with better margin growth, betting on a demand recovery that is not yet in hand.
- The two-year margin bridge: From the current ~13% EBITDA level, the company aims to reach 15% next year and return to 16–17% over two years, implying the recovery is back-end loaded.
Ketan Sablok: "The way the second half has panned out, I don't think we are going to hit that number of Rs. 2,000 crore. Going by the current run rate, I think we should be closer to about Rs. 1,650-1,700 crore, around that number."
Margin & Mix Shift
- Gross margin leap: Consolidated gross margin hit 30% in Q3 FY23 vs 25% a year ago; standalone moved even more sharply from 22% to 29%, driven by moderating RM prices and a conscious shift toward better-margin products.
- New-project hurdle rate: All new projects are targeted at 30%+ gross margin and 18–20% EBITDA, setting a floor that should pull the blended margin up as the mix shifts.
- RM tailwind may persist: Raw material prices kept softening through the quarter, and while management did not call the bottom, the direction of travel is favorable for near-term margins.
- Volume vs price split: In standalone, the revenue fall was more about price corrections than volume loss; in subsidiaries, volume degrowth was the main driver, so the margin benefit from lower RM costs is partly offset by operating deleverage there.
Edward Menezes: "All our new projects are always targeted to 20% EBITDA... most of the projects that we've started would be at least 30% gross margins and about 18% to 20% EBITDA."
Subsidiary Performance & Integration
- Unitop: seasonality, not weakness: Agro is historically strong in H1 and weak in H2 for Unitop over 30 years, so the Q3 dip was expected; volumes should pick up from mid-Feb, and the non-agro business held up well with no destocking.
- Tristar: export destocking hit: European and Russian export demand slowed around November–December, but offtake started recovering from late December; management expects a return to the quarterly run rate in Q4.
- 9M tells the real story: On a year-to-date basis, both subsidiaries performed exceptionally well on top line and margins post-acquisition, and integration of HR, finance and other departments was completed within the first 6–8 months.
- Synergies are becoming tangible: Cross-company product development is underway: spin finish combines Unitop and Rossari capabilities, regenerated cellulose additives draw on both, and a silicone wetter leverages all three entities. Unitop's non-agro business is also being stimulated through Rossari's domestic and export networks.
Standalone & Segment Dynamics
- HPPC held the line: Despite one customer's run rate dropping to zero, HPPC maintained its standalone run rate by adding new customers, including one key MNC onboarded last quarter.
- Textiles: price pain, demand hope: The textile segment saw softening prices as RM costs fell, and export demand remained muted even as domestic demand stayed good; management sees demand picking up from May–June, with Rossari's own textile exports already improving.
- New verticals gaining traction: Recent launches in water treatment, paper, ceramic and cement have received favorable responses, and management is optimistic about growth from these industries in coming years.
- Animal Health push: A conscious decision has been made to promote the Animal Health and Nutrition business aggressively in coming quarters, with new products in the pipeline.
- No big CAPEX needed: Management sees enough headroom in current infrastructure to nearly double turnover, with next year's CAPEX pegged at no more than ₹30–40 crore.
Sunil Chari: "Historically, agro season is strong in the first two quarters for last 30 years for Unitop. So, the third quarter is always a little weak. Therefore, the third and fourth quarters are weak for Unitop."
Competitive Positioning & R&D
- Speed as a moat: Management claims Rossari delivers solutions and products to market faster than most competitors, a capability it ties to the IIT Powai center of excellence and its customised-solution model.
- New product pipeline: Recent R&D output includes green surfactants, silicone-based wetting agents, spin-finish products and in-house ester production, all aimed at widening the addressable market.
- Dismissive of copycats: On competitive threats, the stance is blunt: companies that copy Rossari are not considered competitors, though no evidence was offered to substantiate the defensibility claim.
Edward Menezes: "If you ask somebody in the market, then you will notice that Rossari can really deliver solutions and products to the market much faster than most of our competitors."
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| FY23 top line | Close around ₹1,650–1,700 crore | FY23 (year ending Mar 2023) |
| FY23 EBITDA | ₹220–230 crore | FY23 |
| FY24 top-line growth | At least 15–20% with better margin growth | FY24 |
| EBITDA margin recovery | Move toward 15% next year, 16–17% over two years | FY24 exit / FY25 |
| Tristar export normalization | Return to quarterly run rate | Q4 FY23 |
| Unitop volume pickup | Recovery from seasonal weakness | Mid-Feb 2023 onwards |
| Lost-customer offset | Entirely negate the business loss | Next couple of quarters |
| Textile demand recovery | Pickup in demand | May–June 2023 onwards |
| HPPC doubling | Double the business | 3–4 years |
| AHN doubling | Double the business | 2–3 years |
| Overall sales doubling | Double consolidated sales | 3–4 years |
| FY24 CAPEX | Not more than ₹30–40 crore | FY24 |
Key Metrics
| Metric | Q3 FY23 |
|---|---|
| Consolidated revenue | ₹389 crore, vs ₹428 crore in Q3 FY22 |
| Standalone revenue | ₹237 crore, vs ₹268 crore in Q3 FY22 |
| HPPC revenue | ₹271 crore, 69.7% of consolidated revenue |
| TSC revenue | ₹89.5 crore, 23% of consolidated revenue |
| AHN revenue | ₹28.6 crore, 7.3% of consolidated revenue |
| Consolidated gross margin | 30%, vs 25% in Q3 FY22 |
| Standalone gross margin | 29%, vs 22% in Q3 FY22 |
| Consolidated EBITDA margin | 14%, vs 11% in Q3 FY22 |
| Consolidated EBITDA | ₹54.2 crore, vs ₹56.5 crore in Q2 FY23 |
| Consolidated PAT | ₹25.7 crore, vs ₹23.9 crore in Q2 FY23 |
| Standalone EBITDA | ₹32 crore, vs ₹28 crore in Q2 FY23 |
| Standalone PAT | ₹17.5 crore, vs ₹16.4 crore in Q2 FY23 |
| FY23 revenue guidance (revised) | ₹1,650–1,700 crore, down from earlier ₹2,000 crore |
| FY23 EBITDA guidance (revised) | ₹220–230 crore, down from earlier ₹250 crore |
| FY24 top-line growth outlook | 15% to 20%, with better margin growth |
| EBITDA margin target over next 2 years | 16%–17%, moving up from ~13% in FY23 |
| Capacity utilization | ~55%, with headroom to nearly double turnover |
| Consolidated exports (9M FY23) | ~24% of sales |
| Subsidiary QoQ revenue degrowth | ~9% in Q3 over Q2 |
| CAPEX spends (9M FY23) | ₹5–10 crore |
| FY24 expected CAPEX | not more than ₹30–40 crore |
| HPPC business doubling timeline | 3 to 4 years |
| AHN business doubling timeline | 2 to 3 years |
| Textiles business doubling timeline | 4 to 5 years |
| New project EBITDA target | 18% to 20%, with at least 30% gross margin |
| AHN historical gross margin | upwards of 50% |